APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Starch

Pharmaceutical Starch is an abundantly available natural resource and preferred excipient for drug delivery systems in pharmaceutical solid dosage forms. It is commonly used as a filler, binder, or coating in the drug manufacturing industry.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pharmaceutical Starch is an abundantly available natural resource and preferred excipient for drug delivery systems in pharmaceutical solid dosage forms. It is commonly used as a filler, binder, or coating in the drug manufacturing industry.

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Starch Market Outlook and Growth Opportunities 2026

31 December 2025217 pages

Choose your research edition.

Industry ResearchPharmaceutical Starch Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Starch Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Starch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Starch Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Starch Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Pharmaceutical Starch is an abundantly available natural resource and preferred excipient for drug delivery systems in pharmaceutical solid dosage forms. It is commonly used as a filler, binder, or coating in the drug manufacturing industry.

There are many players in the market, Tereos, Cargill, Roquette, Visco Starch, Colorcon and others are playing important roles in Pharmaceutical Starch industry. Top 5 players occupied about 15.29% market revenue share in 2019, The market is not concentrated for now and is still to be dispersed.

Pharmaceutical starch is widely used as a binding and disintegrating agent for tablets, pills and granules, also used as filler for capsules. By application, Tablets is the largest consumer group, with consumption market share of 57.1% in 2019. Then followed by the Capsule which account for 22.3%.

Read the full market overview

There are many different types of Pharmaceutical Starch. Based on the major consumption types, the market can be segmented into: Corn Starch, Potato Starch and Others. Corn Starch is the most commonly used types and took 90.7% market share in 2019, while Potato Starch took 6.8% market share and Other types took 2.5% in 2019.

As for consumption market, revenue of Pharmaceutical Starch in United States took about 30.1% market share in 2019, which is the biggest consumption country in current market pattern. China ranks the second largest consumption country, with market share of 9.7% in 2019.

This report provides an overview of the global Pharmaceutical Starch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Starch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Starch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Starch market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Starch Segment by Company

Tereos

Cargill

Roquette

Visco Starch

Colorcon

Agrana

Paramesu Biotech

Shandong Liaocheng E Hua Pharmaceutical

SPAC Starch Products (India) Limited

Sanstar Biopolymers Ltd

Ingredion

Shandong Liujia

Universal Starch-Chem Allied Ltd

Hunan Er-Kang Pharmaceutical

Jiangxi Yipusheng Pharmaceutical

Shanxi Mr G Pharmaceutical

Shivangan Food & Pharma

Splenor Starch LLP

Weifang Shengtai Medicine

Taishan Jinantang

Anhui Sunhere Pharmaceutical Excipients

Pharmaceutical Starch Segment by Type

Corn Starch

Potato Starch

Others

Pharmaceutical Starch Segment by Application

Tablets

Capsule

Granular Formulation

Others

Pharmaceutical Starch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Starch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceutical Starch market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Starch significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Starch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Starch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Starch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Starch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Starch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Starch industry.

Chapter 3: Detailed analysis of Pharmaceutical Starch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceutical Starch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceutical Starch in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Starch Industry Trends Table 2. Pharmaceutical Starch Industry Drivers Table 3. Pharmaceutical Starch Industry Opportunities and Challenges Table 4. Pharmaceutical Starch Industry Restraints Table 5. Global Pharmaceutical Starch Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Starch Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Starch Sales Volume by Company (MT) & (2021-2026) Table 8. Global Pharmaceutical Starch Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceutical Starch Average Price (USD/MT) of Company (2021-2026) Table 10. Global Pharmaceutical Starch Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceutical Starch Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceutical Starch Company, Product Type & Application Table 13. Global Pharmaceutical Starch Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Starch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Corn Starch Table 18. Significant Companies of Potato Starch Table 19. Significant Companies of Others Table 20. Global Pharmaceutical Starch Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 21. Global Pharmaceutical Starch Sales Volume by Type (2021-2026) & (MT) Table 22. Global Pharmaceutical Starch Sales Volume by Type (2027-2032) & (MT) Table 23. Global Pharmaceutical Starch Sales Volume Share by Type (2021-2026) Table 24. Global Pharmaceutical Starch Sales Volume Share by Type (2027-2032) Table 25. Global Pharmaceutical Starch Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical Starch Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical Starch Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical Starch Sales Value Share by Type (2021-2026) Table 29. Global Pharmaceutical Starch Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Tablets Table 31. Significant Companies of Capsule Table 32. Significant Companies of Granular Formulation Table 33. Significant Companies of Others Table 34. Global Pharmaceutical Starch Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 35. Global Pharmaceutical Starch Sales Volume by Application (2021-2026) & (MT) Table 36. Global Pharmaceutical Starch Sales Volume by Application (2027-2032) & (MT) Table 37. Global Pharmaceutical Starch Sales Volume Share by Application (2021-2026) Table 38. Global Pharmaceutical Starch Sales Volume Share by Application (2027-2032) Table 39. Global Pharmaceutical Starch Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Pharmaceutical Starch Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Pharmaceutical Starch Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Pharmaceutical Starch Sales Value Share by Application (2021-2026) Table 43. Global Pharmaceutical Starch Sales Value Share by Application (2027-2032) Table 44. Global Pharmaceutical Starch Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 45. Global Pharmaceutical Starch Sales by Region (2021-2026) & (MT) Table 46. Global Pharmaceutical Starch Sales Market Share by Region (2021-2026) Table 47. Global Pharmaceutical Starch Sales by Region (2027-2032) & (MT) Table 48. Global Pharmaceutical Starch Sales Market Share by Region (2027-2032) Table 49. Global Pharmaceutical Starch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pharmaceutical Starch Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Pharmaceutical Starch Sales Value Share by Region (2021-2026) Table 52. Global Pharmaceutical Starch Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Pharmaceutical Starch Sales Value Share by Region (2027-2032) Table 54. Global Pharmaceutical Starch Market Average Price (USD/MT) by Region (2021-2026) Table 55. Global Pharmaceutical Starch Market Average Price (USD/MT) by Region (2027-2032) Table 56. Global Pharmaceutical Starch Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 57. Global Pharmaceutical Starch Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pharmaceutical Starch Sales by Country (2021-2026) & (MT) Table 59. Global Pharmaceutical Starch Sales Market Share by Country (2021-2026) Table 60. Global Pharmaceutical Starch Sales by Country (2027-2032) & (MT) Table 61. Global Pharmaceutical Starch Sales Market Share by Country (2027-2032) Table 62. Global Pharmaceutical Starch Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Pharmaceutical Starch Sales Value Market Share by Country (2021-2026) Table 64. Global Pharmaceutical Starch Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Pharmaceutical Starch Sales Value Market Share by Country (2027-2032) Table 66. Tereos Company Information Table 67. Tereos Business Overview Table 68. Tereos Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 69. Tereos Pharmaceutical Starch Product Portfolio Table 70. Tereos Recent Development Table 71. Cargill Company Information Table 72. Cargill Business Overview Table 73. Cargill Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 74. Cargill Pharmaceutical Starch Product Portfolio Table 75. Cargill Recent Development Table 76. Roquette Company Information Table 77. Roquette Business Overview Table 78. Roquette Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 79. Roquette Pharmaceutical Starch Product Portfolio Table 80. Roquette Recent Development Table 81. Visco Starch Company Information Table 82. Visco Starch Business Overview Table 83. Visco Starch Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 84. Visco Starch Pharmaceutical Starch Product Portfolio Table 85. Visco Starch Recent Development Table 86. Colorcon Company Information Table 87. Colorcon Business Overview Table 88. Colorcon Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 89. Colorcon Pharmaceutical Starch Product Portfolio Table 90. Colorcon Recent Development Table 91. Agrana Company Information Table 92. Agrana Business Overview Table 93. Agrana Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 94. Agrana Pharmaceutical Starch Product Portfolio Table 95. Agrana Recent Development Table 96. Paramesu Biotech Company Information Table 97. Paramesu Biotech Business Overview Table 98. Paramesu Biotech Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 99. Paramesu Biotech Pharmaceutical Starch Product Portfolio Table 100. Paramesu Biotech Recent Development Table 101. Shandong Liaocheng E Hua Pharmaceutical Company Information Table 102. Shandong Liaocheng E Hua Pharmaceutical Business Overview Table 103. Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 104. Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Product Portfolio Table 105. Shandong Liaocheng E Hua Pharmaceutical Recent Development Table 106. SPAC Starch Products (India) Limited Company Information Table 107. SPAC Starch Products (India) Limited Business Overview Table 108. SPAC Starch Products (India) Limited Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 109. SPAC Starch Products (India) Limited Pharmaceutical Starch Product Portfolio Table 110. SPAC Starch Products (India) Limited Recent Development Table 111. Sanstar Biopolymers Ltd Company Information Table 112. Sanstar Biopolymers Ltd Business Overview Table 113. Sanstar Biopolymers Ltd Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 114. Sanstar Biopolymers Ltd Pharmaceutical Starch Product Portfolio Table 115. Sanstar Biopolymers Ltd Recent Development Table 116. Ingredion Company Information Table 117. Ingredion Business Overview Table 118. Ingredion Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 119. Ingredion Pharmaceutical Starch Product Portfolio Table 120. Ingredion Recent Development Table 121. Shandong Liujia Company Information Table 122. Shandong Liujia Business Overview Table 123. Shandong Liujia Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 124. Shandong Liujia Pharmaceutical Starch Product Portfolio Table 125. Shandong Liujia Recent Development Table 126. Universal Starch-Chem Allied Ltd Company Information Table 127. Universal Starch-Chem Allied Ltd Business Overview Table 128. Universal Starch-Chem Allied Ltd Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 129. Universal Starch-Chem Allied Ltd Pharmaceutical Starch Product Portfolio Table 130. Universal Starch-Chem Allied Ltd Recent Development Table 131. Hunan Er-Kang Pharmaceutical Company Information Table 132. Hunan Er-Kang Pharmaceutical Business Overview Table 133. Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 134. Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Product Portfolio Table 135. Hunan Er-Kang Pharmaceutical Recent Development Table 136. Jiangxi Yipusheng Pharmaceutical Company Information Table 137. Jiangxi Yipusheng Pharmaceutical Business Overview Table 138. Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 139. Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Product Portfolio Table 140. Jiangxi Yipusheng Pharmaceutical Recent Development Table 141. Shanxi Mr G Pharmaceutical Company Information Table 142. Shanxi Mr G Pharmaceutical Business Overview Table 143. Shanxi Mr G Pharmaceutical Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 144. Shanxi Mr G Pharmaceutical Pharmaceutical Starch Product Portfolio Table 145. Shanxi Mr G Pharmaceutical Recent Development Table 146. Shivangan Food & Pharma Company Information Table 147. Shivangan Food & Pharma Business Overview Table 148. Shivangan Food & Pharma Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 149. Shivangan Food & Pharma Pharmaceutical Starch Product Portfolio Table 150. Shivangan Food & Pharma Recent Development Table 151. Splenor Starch LLP Company Information Table 152. Splenor Starch LLP Business Overview Table 153. Splenor Starch LLP Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 154. Splenor Starch LLP Pharmaceutical Starch Product Portfolio Table 155. Splenor Starch LLP Recent Development Table 156. Weifang Shengtai Medicine Company Information Table 157. Weifang Shengtai Medicine Business Overview Table 158. Weifang Shengtai Medicine Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 159. Weifang Shengtai Medicine Pharmaceutical Starch Product Portfolio Table 160. Weifang Shengtai Medicine Recent Development Table 161. Taishan Jinantang Company Information Table 162. Taishan Jinantang Business Overview Table 163. Taishan Jinantang Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 164. Taishan Jinantang Pharmaceutical Starch Product Portfolio Table 165. Taishan Jinantang Recent Development Table 166. Anhui Sunhere Pharmaceutical Excipients Company Information Table 167. Anhui Sunhere Pharmaceutical Excipients Business Overview Table 168. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 169. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Product Portfolio Table 170. Anhui Sunhere Pharmaceutical Excipients Recent Development Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Pharmaceutical Starch Distributors List Table 174. Pharmaceutical Starch Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Pharmaceutical Starch Product Image Figure 2. Global Pharmaceutical Starch Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Starch Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Starch Sales (2021-2032) & (MT) Figure 5. Global Pharmaceutical Starch Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global Pharmaceutical Starch Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Corn Starch Image Figure 10. Potato Starch Image Figure 11. Others Image Figure 12. Global Pharmaceutical Starch Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 13. Global Pharmaceutical Starch Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Starch Sales Volume Share by Type (2021-2032) Figure 15. Global Pharmaceutical Starch Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pharmaceutical Starch Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceutical Starch Sales Value Share by Type (2021-2032) Figure 18. Tablets Image Figure 19. Capsule Image Figure 20. Granular Formulation Image Figure 21. Others Image Figure 22. Global Pharmaceutical Starch Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 23. Global Pharmaceutical Starch Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Pharmaceutical Starch Sales Volume Share by Application (2021-2032) Figure 25. Global Pharmaceutical Starch Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Pharmaceutical Starch Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Pharmaceutical Starch Sales Value Share by Application (2021-2032) Figure 28. Global Pharmaceutical Starch Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 29. Global Pharmaceutical Starch Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Pharmaceutical Starch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Pharmaceutical Starch Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Pharmaceutical Starch Sales Value (2021-2032) & (US$ Million) Figure 33. North America Pharmaceutical Starch Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Pharmaceutical Starch Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Pharmaceutical Starch Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Pharmaceutical Starch Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Pharmaceutical Starch Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Pharmaceutical Starch Sales Value (2021-2032) & (US$ Million) Figure 39. South America Pharmaceutical Starch Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Pharmaceutical Starch Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Pharmaceutical Starch Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Pharmaceutical Starch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Pharmaceutical Starch Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Pharmaceutical Starch Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Corn Starch
  • Potato Starch
  • Others
Applications
  • Tablets
  • Capsule
  • Granular Formulation
  • Others
Companies covered
  • Tereos
  • Cargill
  • Roquette
  • Visco Starch
  • Colorcon
  • Agrana
  • Paramesu Biotech
  • Shandong Liaocheng E Hua Pharmaceutical
  • SPAC Starch Products (India) Limited
  • Sanstar Biopolymers Ltd
  • Ingredion
  • Shandong Liujia
  • Universal Starch-Chem Allied Ltd
  • Hunan Er-Kang Pharmaceutical
  • Jiangxi Yipusheng Pharmaceutical
  • Shanxi Mr G Pharmaceutical
  • Shivangan Food & Pharma
  • Splenor Starch LLP
  • Weifang Shengtai Medicine
  • Taishan Jinantang
  • Anhui Sunhere Pharmaceutical Excipients

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Starch Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceutical Starch Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceutical Starch Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceutical Starch Market Dynamics
  1. 2.1 Pharmaceutical Starch Industry Trends
  2. 2.2 Pharmaceutical Starch Industry Drivers
  3. 2.3 Pharmaceutical Starch Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Starch Industry Restraints
3 Pharmaceutical Starch Market by Company
  1. 3.1 Global Pharmaceutical Starch Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Starch Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Starch Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceutical Starch Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceutical Starch Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceutical Starch Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceutical Starch Company Product Type and Application
  8. 3.8 Global Pharmaceutical Starch Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceutical Starch Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceutical Starch Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceutical Starch Market by Type
  1. 4.1 Pharmaceutical Starch Type Introduction
  2. 4.1.1 Corn Starch
  3. 4.1.2 Potato Starch
  4. 4.1.3 Others
  5. 4.2 Global Pharmaceutical Starch Sales Volume by Type
  6. 4.2.1 Global Pharmaceutical Starch Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pharmaceutical Starch Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Pharmaceutical Starch Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Pharmaceutical Starch Sales Value by Type
  10. 4.3.1 Global Pharmaceutical Starch Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pharmaceutical Starch Sales Value by Type (2021-2032)
  12. 4.3.3 Global Pharmaceutical Starch Sales Value Share by Type (2021-2032)
5 Pharmaceutical Starch Market by Application
  1. 5.1 Pharmaceutical Starch Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Capsule
  4. 5.1.3 Granular Formulation
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical Starch Sales Volume by Application
  7. 5.2.1 Global Pharmaceutical Starch Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical Starch Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical Starch Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pharmaceutical Starch Sales Value by Application
  11. 5.3.1 Global Pharmaceutical Starch Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pharmaceutical Starch Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pharmaceutical Starch Sales Value Share by Application (2021-2032)
6 Pharmaceutical Starch Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceutical Starch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Starch Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Starch Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Starch Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceutical Starch Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceutical Starch Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceutical Starch Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceutical Starch Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceutical Starch Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceutical Starch Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceutical Starch Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceutical Starch Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceutical Starch Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceutical Starch Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceutical Starch Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceutical Starch Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceutical Starch Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceutical Starch Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceutical Starch Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Starch Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceutical Starch Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Starch Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceutical Starch Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceutical Starch Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceutical Starch Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceutical Starch Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceutical Starch Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceutical Starch Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceutical Starch Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceutical Starch Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceutical Starch Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tereos
  2. 8.1.1 Tereos Company Information
  3. 8.1.2 Tereos Business Overview
  4. 8.1.3 Tereos Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tereos Pharmaceutical Starch Product Portfolio
  6. 8.1.5 Tereos Recent Developments
  7. 8.2 Cargill
  8. 8.2.1 Cargill Company Information
  9. 8.2.2 Cargill Business Overview
  10. 8.2.3 Cargill Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cargill Pharmaceutical Starch Product Portfolio
  12. 8.2.5 Cargill Recent Developments
  13. 8.3 Roquette
  14. 8.3.1 Roquette Company Information
  15. 8.3.2 Roquette Business Overview
  16. 8.3.3 Roquette Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Roquette Pharmaceutical Starch Product Portfolio
  18. 8.3.5 Roquette Recent Developments
  19. 8.4 Visco Starch
  20. 8.4.1 Visco Starch Company Information
  21. 8.4.2 Visco Starch Business Overview
  22. 8.4.3 Visco Starch Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Visco Starch Pharmaceutical Starch Product Portfolio
  24. 8.4.5 Visco Starch Recent Developments
  25. 8.5 Colorcon
  26. 8.5.1 Colorcon Company Information
  27. 8.5.2 Colorcon Business Overview
  28. 8.5.3 Colorcon Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Colorcon Pharmaceutical Starch Product Portfolio
  30. 8.5.5 Colorcon Recent Developments
  31. 8.6 Agrana
  32. 8.6.1 Agrana Company Information
  33. 8.6.2 Agrana Business Overview
  34. 8.6.3 Agrana Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Agrana Pharmaceutical Starch Product Portfolio
  36. 8.6.5 Agrana Recent Developments
  37. 8.7 Paramesu Biotech
  38. 8.7.1 Paramesu Biotech Company Information
  39. 8.7.2 Paramesu Biotech Business Overview
  40. 8.7.3 Paramesu Biotech Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Paramesu Biotech Pharmaceutical Starch Product Portfolio
  42. 8.7.5 Paramesu Biotech Recent Developments
  43. 8.8 Shandong Liaocheng E Hua Pharmaceutical
  44. 8.8.1 Shandong Liaocheng E Hua Pharmaceutical Company Information
  45. 8.8.2 Shandong Liaocheng E Hua Pharmaceutical Business Overview
  46. 8.8.3 Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shandong Liaocheng E Hua Pharmaceutical Pharmaceutical Starch Product Portfolio
  48. 8.8.5 Shandong Liaocheng E Hua Pharmaceutical Recent Developments
  49. 8.9 SPAC Starch Products (India) Limited
  50. 8.9.1 SPAC Starch Products (India) Limited Company Information
  51. 8.9.2 SPAC Starch Products (India) Limited Business Overview
  52. 8.9.3 SPAC Starch Products (India) Limited Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 SPAC Starch Products (India) Limited Pharmaceutical Starch Product Portfolio
  54. 8.9.5 SPAC Starch Products (India) Limited Recent Developments
  55. 8.10 Sanstar Biopolymers Ltd
  56. 8.10.1 Sanstar Biopolymers Ltd Company Information
  57. 8.10.2 Sanstar Biopolymers Ltd Business Overview
  58. 8.10.3 Sanstar Biopolymers Ltd Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sanstar Biopolymers Ltd Pharmaceutical Starch Product Portfolio
  60. 8.10.5 Sanstar Biopolymers Ltd Recent Developments
  61. 8.11 Ingredion
  62. 8.11.1 Ingredion Company Information
  63. 8.11.2 Ingredion Business Overview
  64. 8.11.3 Ingredion Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ingredion Pharmaceutical Starch Product Portfolio
  66. 8.11.5 Ingredion Recent Developments
  67. 8.12 Shandong Liujia
  68. 8.12.1 Shandong Liujia Company Information
  69. 8.12.2 Shandong Liujia Business Overview
  70. 8.12.3 Shandong Liujia Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Shandong Liujia Pharmaceutical Starch Product Portfolio
  72. 8.12.5 Shandong Liujia Recent Developments
  73. 8.13 Universal Starch-Chem Allied Ltd
  74. 8.13.1 Universal Starch-Chem Allied Ltd Company Information
  75. 8.13.2 Universal Starch-Chem Allied Ltd Business Overview
  76. 8.13.3 Universal Starch-Chem Allied Ltd Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Universal Starch-Chem Allied Ltd Pharmaceutical Starch Product Portfolio
  78. 8.13.5 Universal Starch-Chem Allied Ltd Recent Developments
  79. 8.14 Hunan Er-Kang Pharmaceutical
  80. 8.14.1 Hunan Er-Kang Pharmaceutical Company Information
  81. 8.14.2 Hunan Er-Kang Pharmaceutical Business Overview
  82. 8.14.3 Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Hunan Er-Kang Pharmaceutical Pharmaceutical Starch Product Portfolio
  84. 8.14.5 Hunan Er-Kang Pharmaceutical Recent Developments
  85. 8.15 Jiangxi Yipusheng Pharmaceutical
  86. 8.15.1 Jiangxi Yipusheng Pharmaceutical Company Information
  87. 8.15.2 Jiangxi Yipusheng Pharmaceutical Business Overview
  88. 8.15.3 Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Jiangxi Yipusheng Pharmaceutical Pharmaceutical Starch Product Portfolio
  90. 8.15.5 Jiangxi Yipusheng Pharmaceutical Recent Developments
  91. 8.16 Shanxi Mr G Pharmaceutical
  92. 8.16.1 Shanxi Mr G Pharmaceutical Company Information
  93. 8.16.2 Shanxi Mr G Pharmaceutical Business Overview
  94. 8.16.3 Shanxi Mr G Pharmaceutical Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Shanxi Mr G Pharmaceutical Pharmaceutical Starch Product Portfolio
  96. 8.16.5 Shanxi Mr G Pharmaceutical Recent Developments
  97. 8.17 Shivangan Food & Pharma
  98. 8.17.1 Shivangan Food & Pharma Company Information
  99. 8.17.2 Shivangan Food & Pharma Business Overview
  100. 8.17.3 Shivangan Food & Pharma Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Shivangan Food & Pharma Pharmaceutical Starch Product Portfolio
  102. 8.17.5 Shivangan Food & Pharma Recent Developments
  103. 8.18 Splenor Starch LLP
  104. 8.18.1 Splenor Starch LLP Company Information
  105. 8.18.2 Splenor Starch LLP Business Overview
  106. 8.18.3 Splenor Starch LLP Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Splenor Starch LLP Pharmaceutical Starch Product Portfolio
  108. 8.18.5 Splenor Starch LLP Recent Developments
  109. 8.19 Weifang Shengtai Medicine
  110. 8.19.1 Weifang Shengtai Medicine Company Information
  111. 8.19.2 Weifang Shengtai Medicine Business Overview
  112. 8.19.3 Weifang Shengtai Medicine Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Weifang Shengtai Medicine Pharmaceutical Starch Product Portfolio
  114. 8.19.5 Weifang Shengtai Medicine Recent Developments
  115. 8.20 Taishan Jinantang
  116. 8.20.1 Taishan Jinantang Company Information
  117. 8.20.2 Taishan Jinantang Business Overview
  118. 8.20.3 Taishan Jinantang Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Taishan Jinantang Pharmaceutical Starch Product Portfolio
  120. 8.20.5 Taishan Jinantang Recent Developments
  121. 8.21 Anhui Sunhere Pharmaceutical Excipients
  122. 8.21.1 Anhui Sunhere Pharmaceutical Excipients Company Information
  123. 8.21.2 Anhui Sunhere Pharmaceutical Excipients Business Overview
  124. 8.21.3 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Starch Product Portfolio
  126. 8.21.5 Anhui Sunhere Pharmaceutical Excipients Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Starch Value Chain Analysis
  2. 9.1.1 Pharmaceutical Starch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Starch Sales Mode & Process
  6. 9.2 Pharmaceutical Starch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Starch Distributors
  9. 9.2.3 Pharmaceutical Starch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst